Common use of Press Releases and Other Disclosures Clause in Contracts

Press Releases and Other Disclosures. The Parties will cooperate in the distribution of the initial press release relating to this Agreement set forth in Exhibit D to this Agreement. Except as expressly permitted under this Section or required by Law, neither Party will make any public announcement of any information regarding this Agreement either directly or indirectly, without first obtaining the written approval of the other Party; provided, however, that TransTech may make a public announcement of or otherwise disclose the results of any clinical trial relating to Licensed Products without first obtaining the written approval of Novo. Once any public statement or disclosure has been approved in accordance with this Section, then either Party may appropriately communicate information contained in such permitted statement or disclosure. Notwithstanding the foregoing provisions of this Section 11.12 or Article VI, a Party may disclose the existence and terms of the this Agreement (a) where required, as reasonably determined by the disclosing Party, by applicable Law, by applicable stock exchange regulation or by order or other ruling of a competent court or (b) under obligations of confidentiality as least as stringent as those set forth in this Agreement, to agents, directors, officers, employees, consultants, contractors, licensees, partners, investors, investors’ representatives, acquirers, acquirer’s representatives and advisors, and to potential agents, consultants, contractors, licensees, partners, investors, investors’ representatives, acquirers, acquirer’s representatives and advisors, in connection with (i) the discovery, Development, Manufacture or Commercialization of Licensed Products pursuant to this Agreement, including negotiations with potential Commercialization Partners or (ii) such Party’s financing activities, corporate restructuring or sale.

Press Releases and Other Disclosures. The Parties will cooperate in the distribution of the initial No press release relating to or other public announcement concerning the existence or terms of this Agreement set forth in Exhibit D to this Agreement. Except as expressly permitted under this Section or required by Lawshall be made, neither Party will make any public announcement of any information regarding this Agreement either directly or indirectly, by either Party hereto, without first obtaining the written approval of the other Party; provided, however, that TransTech may make a public announcement of or otherwise disclose the results of any clinical trial relating to Licensed Products without first obtaining the written approval of Novo. Once any public statement announcement or disclosure has been approved in accordance with this SectionSection 7.5, then either Party may appropriately communicate information contained in such permitted statement announcement or disclosure. Notwithstanding the foregoing provisions of this Section 11.12 or Article VI, a Party ARTICLE 7 Company may (a) disclose the existence and terms of the this Agreement (a) where required, as reasonably determined by the disclosing PartyCompany, by applicable Law, by applicable stock exchange or Nasdaq regulation or by order or other ruling of a competent court or and (b) disclose the existence and terms of this Agreement under obligations of confidentiality to auditors, legal counsel and investment bankers in connection with exploring the issuance of securities in a public transaction; provided, however, that before making any such disclosure, prior written notice is given to CDC together with a description of the disclosure that is intended to be made and the party or parties to whom such disclosure shall be made. Notwithstanding the foregoing provisions of this ARTICLE 7, CDC may (a) disclose the existence and terms of this Agreement where required, as least as stringent as those set forth in reasonably determined by the CDC, by applicable Law, by applicable stock exchange or Nasdaq regulation or by order or other ruling of a competent court and (b) disclose the existence and terms of this Agreement, Agreement under obligations of confidentiality to agents, directorsauditors, officers, employees, consultants, contractors, licensees, partners, investors, investors’ representatives, acquirers, acquirer’s representatives and advisors, contractors and investors and to potential agents, consultantsauditors, contractors, licensees, partners, investors, investors’ representatives, acquirers, acquirer’s representatives and advisors, contractors and investors (including any assignee or purchaser of any rights hereunder) in connection with (i) the discovery, Development, Manufacture or Commercialization of Licensed Products pursuant to this Agreement, including negotiations such CDC’s activities hereunder and in connection with potential Commercialization Partners or (ii) such Party’s financing activities, corporate restructuring or sale.